Navigation Links
Algos Attracts CRO Veteran Dr. Ganesh Iyer as its New CEO
Date:10/1/2009

ST. PAUL, Minn., Oct. 1 /PRNewswire/ -- Algos Therapeutics Inc., a Minnesota-based global preclinical contract research organization (CRO) today announces the selection of Dr. Ganesh Iyer as its new president and CEO. Dr. Iyer will assume his new responsibilities immediately.

"We were incredibly fortunate to have attracted such a uniquely qualified executive as Dr. Iyer to lead Algos," stated Gary Smaby, Algos Board Chair and managing partner for Quatris Fund, the Company's lead investor. "Dr. Iyer possesses the rare combination of scientific expertise and business acumen needed to lead Algos in the deployment of the Company's new service-based CRO model focused on assisting leading pharmaceutical companies in bringing their technological breakthroughs to the marketplace," adds Mr. Smaby.

Until recently, Dr. Iyer was Director of Strategic Analysis and Business Operations at MDS Pharma Services. Dr. Iyer has over 16 years of strategic and business development experience with prominent biotech and high-tech companies ranging from R&D start-ups to F500 companies, including ZymoGenetics/Novo Nordisk, Xcyte Therapies, SkeleTech, MDS Pharma Services and Microsoft. Dr. Iyer holds a Ph.D. in Chemical Engineering from Purdue University and an M.B.A. from Seattle University.

"I am very excited about joining Algos and look forward to working with an excellent team to achieving our mission and goal to become the premier preclinical in vivo pain research services company," commented Dr. Iyer.

About Algos Therapeutics:

Founded as Algos Therapeutics, Inc. in 2003, the company recently changed its corporate identity to Algos Preclinical Services to reflect its new strategic market positioning as a US-based preclinical, in vivo CRO that provides contract research services to pharmaceutical, biotech and medical device markets. Algos Preclinical supports the development of its customers' products from its facilities in St. Paul, MN USA.

Visit Algos' website at www.Algosinc.com

SOURCE Algos Preclinical Services


'/>"/>
SOURCE Algos Preclinical Services
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. For Iraq Veterans, Headaches Continue After Traumatic Brain Injury
2. NovaRx Appoints Industry Veteran as President and COO
3. Congresswoman Supporting Spinal Cord Research Intended to Benefit U.S. Veterans
4. Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
5. Secretary Reinforces VAs Commitment to Research Safety and Veteran Focus
6. MultiVu Video Feed: Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals Important Cardiovascular Safety News on AVANDIA
7. Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals Important Cardiovascular Safety News on AVANDIA(R)
8. American Legion Anticipates Institute of Medicine Report on Gulf War Veterans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... -- Commended for their devotion to personalized service, SMP Pharmacy Solutions ... in the South Florida Business Journal,s 50 Fastest-Growing Companies, and ... the national specialty pharmacy has found its niche.  To that ... be honored by SFBJ as the 2017 Power Leader in ... receive his award in October, Bardisa said of the three ...
Breaking Medicine Technology:
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... MD (PRWEB) , ... October 12, 2017 , ... The ... of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual ... – 8. , In honor of Morris F. Collen, a pioneer in the field ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... , ... October 12, 2017 , ... HMP , ... recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ ... on October 11, 2017. , The annual award competition recognizes editorial and design excellence ...
(Date:10/12/2017)... Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... is holding a treadmill relay – Miles by Moonlight to raise money for the ... donating $300 or more. , Teams will work together to keep their treadmills ...
Breaking Medicine News(10 mins):